Emily F. Davis-Marcisak

Author

Also Known As

Arora, Arshi, Davis-Marcisak, Emily F., E Davis, E. Davis, Emily Davis, Emily Davis-Marcisak, Emily F Marcisak, Emily F. Davis, Emily F. Davis-Marcisak, Emily F. Marcisak

110

Publications

1.9K

Citations

H-Index

Concepts

All Affiliations

Johns Hopkins University Johns Hopkins Medicine Sidney Kimmel Comprehensive Cancer Center Ohio University Biotechnology Institute

About

Emily F. Davis-Marcisak is an author at Johns Hopkins University specializing in medicine, cell biology, and gene expression.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	879
2	Natural Sciences	2	2	49
3	Health Sciences	1	1	27
4	Public Health	1	1	90
5	Biochemistry	1	1	16

Emily F. Davis-Marcisak

Publications

1.5K

Citations

H-Index

Page 1

	Year	Citations
Single-Cell RNA-Seq Analysis of Retinal Development Identifies NFI Factors as Regulating Mitotic Exit and Late-Born Cell Specification Brian S. Clark, Genevieve Stein-O’Brien, Fion Shiau, Neuron Cell LineageDevelopmental BiologyRetinaCell DivisionLate-born Cell Specification	2019	588
Residual function of cystic fibrosis mutants predicts response to small molecule CFTR modulators Sangwoo T. Han, András Rab, Matthew J. Pellicore, JCI Insight	2018	100
Correlating Cystic Fibrosis Transmembrane Conductance Regulator Function with Clinical Features to Inform Precision Treatment of Cystic Fibrosis Allison F. McCague, Karen S. Raraigh, Matthew J. Pellicore, American Journal of Respiratory and Critical Care Medicine	2019	92
Functional Assays Are Essential for Interpretation of Missense Variants Associated with Variable Expressivity Karen S. Raraigh, Sangwoo T. Han, Emily F. Davis-Marcisak, The American Journal of Human Genetics Allelic VariantGenotype-phenotype AssociationGenetic DisorderGeneticsStatistical Genetics	2018	90
Systematic Computational Identification of Variants That Activate Exonic and Intronic Cryptic Splice Sites Melissa Lee, Patrick Roos, Neeraj Sharma, The American Journal of Human Genetics Sequence MotifFunctional GenomicsSystematic Computational IdentificationGeneticsActivate Exonic	2017	76
DPP inhibition alters the CXCR3 axis and enhances NK and CD8+ T cell infiltration to improve anti-PD1 efficacy in murine models of pancreatic ductal adenocarcinoma Allison A. Fitzgerald, Shangzi Wang, Veena R. Agarwal, Journal for ImmunoTherapy of Cancer	2021	72
Capitalizing on the heterogeneous effects of CFTR nonsense and frameshift variants to inform therapeutic strategy for cystic fibrosis Neeraj Sharma, Taylor A. Evans, Matthew J. Pellicore, PLoS Genetics FibrosisMolecular PhysiologyProtein ExpressionMedicinePathology	2018	63
Integrated single-cell and bulk gene expression and ATAC-seq reveals heterogeneity and early changes in pathways associated with resistance to cetuximab in HNSCC-sensitive cell lines Luciane T. Kagohara, Fernando T. Zamunér, Emily F. Davis-Marcisak, British Journal of Cancer	2020	55
Saccharin Derivatives as Inhibitors of Interferon-Mediated Inflammation Adam Csakai, Christina Smith, Emily F. Davis-Marcisak, Journal of Medicinal Chemistry	2014	43
Differential Variation Analysis Enables Detection of Tumor Heterogeneity Using Single-Cell RNA-Sequencing Data Emily F. Davis-Marcisak, Thomas D. Sherman, Pranay Orugunta, Cancer Research	2019	37

Page 1